{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:51:44Z","timestamp":1790095904033,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1999,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Lorraine Universit\u00e9 d'Excellence","award":["ANR-15-IDEX-04-LUE"],"award-info":[{"award-number":["ANR-15-IDEX-04-LUE"]}]},{"name":"RHU Fight-HF","award":["ANR-15-RHUS-0004"],"award-info":[{"award-number":["ANR-15-RHUS-0004"]}]},{"name":"Lorraine Universit\u00e9 d'Excellence","award":["ANR-15-IDEX-04-LUE"],"award-info":[{"award-number":["ANR-15-IDEX-04-LUE"]}]},{"name":"RHU Fight-HF","award":["ANR-15-RHUS-0004"],"award-info":[{"award-number":["ANR-15-RHUS-0004"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>How general practitioners (GPs) manage dyskalaemia is currently unknown. This study aimed at describing GP practices regarding hypokalaemia or hyperkalaemia diagnosis and management in their outpatients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A telephone survey was conducted among French GPs with a 20-item questionnaire (16 closed-ended questions and 12 open-ended questions) regarding their usual management of hypokalaemia or hyperkalaemia patients, both broadly and more specifically in patients with heart failure and\/or chronic kidney disease and\/or in patients treated with angiotensin-converting enzyme\/angiotensin receptor blockers or mineralocorticoid receptor antagonists. We aimed to interview 500 GPs spread geographically throughout France. This descriptive survey results are presented as mean \u00b1 standard deviation (if normally distributed or as median and inter-quartile range if the distribution was skewed). Categorical variables are expressed as frequencies and proportions (%). A total of 500 GPs participated in the study. Dyskalaemia thresholds (for diagnosis and intervention) and management patterns were highly heterogeneous. The mean \u00b1 SD (range) potassium level leading to \u2018intervene\u2019 was 5.32 \u00b1 0.34 mmol\/L (4.5\u20136.5) for hyperkalaemia and 3.23 \u00b1 0.34 mmol\/L (2.0\u20136.5) for hypokalaemia. Potassium levels leading to refer the patient to the emergency department (ED) were 6.14 \u00b1 0.55 (4.5\u201310) and 2.69 \u00b1 0.42 mmol\/L (1\u20134), respectively. Potassium binders (51\u201365%) or potassium supplements (67\u201374%) were frequently used to manage hyperkalaemia or hypokalaemia. GPs uncommonly referred their dyskalaemic patients to cardiologists or nephrologists (or to the emergency department, if the latter was deemed necessary owing to the severity of the dyskalaemia). We identified an association between the close vicinity of GP office from an ED and \u2018referring a heart failure patient\u2019 (19.2% with ED vs. 8.6% without ED) and referring a heart failure and chronic kidney disease patient on mineralocorticoid receptor antagonist (16.7% with ED vs. 9.3% without ED). Although the majority (67%) of GPs had an electrocardiogram on hand, it was rarely used (14%) in dyskalaemic patients. Subgroup analyses considering gender, age of the participating GPs, and high-income\/low-income regions did not identify specific patterns regarding the multidimensional aspect of dyskalaemia management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Owing to the considerable heterogeneity of French GP practices toward dyskalaemia diagnosis and management approaches, there is a likely need to standardize (potentially enabled by therapeutic algorithms) practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12834","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T02:53:20Z","timestamp":1593485600000},"page":"2042-2050","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperkalaemia and Hypokalaemia Outpatient Management: A Survey of 500 French General Practitioners"],"prefix":"10.1093","volume":"7","author":[{"given":"Laure","family":"Abensur Vuillaume","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 1433, and Inserm 1116 DCAC, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]},{"name":"Emergency Department, Centre Hospitalier R\u00e9gional Metz-Thionville , Metz ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol*","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 1433, and Inserm 1116 DCAC, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Lamiral","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 1433, and Inserm 1116 DCAC, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 1433, and Inserm 1116 DCAC, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Boivin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurith\u00e9matique 1433, and Inserm 1116 DCAC, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"2026012114053126900_ehf212834-bib-0001","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.030576","article-title":"Long-term potassium monitoring and dynamics in heart failure and risk of mortality","volume":"137","author":"Nunez","year":"2017","journal-title":"Circulation"},{"key":"2026012114053126900_ehf212834-bib-0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"2026012114053126900_ehf212834-bib-0003","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1724","article-title":"Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction","author":"Rossignol","year":"2020","journal-title":"Eur J H Fail"},{"key":"2026012114053126900_ehf212834-bib-0004","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1093\/eurheartj\/suy032","article-title":"A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology","volume":"21","author":"Rossignol","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"2026012114053126900_ehf212834-bib-0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012114053126900_ehf212834-bib-0006","volume-title":"Clinical practice guidelines treatment of acute hyperkalaemia in adults","author":"Alfonzo","year":"2014"},{"key":"2026012114053126900_ehf212834-bib-0007","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.resuscitation.2015.07.017","article-title":"European resuscitation council guidelines for resuscitation 2015","volume":"95","author":"Truhl\u00e1\u0159","year":"2015","journal-title":"Resuscitation"},{"key":"2026012114053126900_ehf212834-bib-0008","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-019-0509-8","article-title":"Management of hyperkalemia in the acutely ill patient","volume":"9","author":"D\u00e9pret","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2026012114053126900_ehf212834-bib-0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.phrs.2016.09.039","article-title":"Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future","volume":"113","author":"Rossignol","year":"2016","journal-title":"Pharmacol Res"},{"key":"2026012114053126900_ehf212834-bib-0010","volume-title":"Les dyskali\u00e9mies","author":"Garcia","year":"1999"},{"key":"2026012114053126900_ehf212834-bib-0011","volume-title":"Concevoir, traduire et valider un questionnaire. A propos d'un exemple EUROQUEST. Notes scientifiques et techniques de l'INRS NS 178","author":"Bouletreau","year":"1999"},{"key":"2026012114053126900_ehf212834-bib-0012","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1053\/ajem.2000.7344","article-title":"Electrocardiographic manifestations of hyperkalemia","volume":"18","author":"Mattu","year":"2000","journal-title":"Am J Emerg Med"},{"key":"2026012114053126900_ehf212834-bib-0013","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2215\/CJN.04611007","article-title":"Retrospective review of the frequency of ECG changes in hyperkalemia","volume":"3","author":"Montague","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012114053126900_ehf212834-bib-0014","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamacardio.2019.0640","article-title":"Development and validation of a deep-learning model to screen for hyperkalemia from the electrocardiogram","volume":"4","author":"Galloway","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026012114053126900_ehf212834-bib-0015","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.amjmed.2015.05.040","article-title":"Management of hyperkalemia: an update for the internist","volume":"128","author":"Kovesdy","year":"2015","journal-title":"Am J Med"},{"key":"2026012114053126900_ehf212834-bib-0016","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"2026012114053126900_ehf212834-bib-0017","article-title":"Recurrent hyperkalaemia management and use of reninangiotensin-aldosterone system inhibitors. A European multi-national targeted chart review","author":"Rossignol","year":"2019","journal-title":"Clin Kidney J"},{"key":"2026012114053126900_ehf212834-bib-0018","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin\u2013angiotensin\u2013aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012114053126900_ehf212834-bib-0019","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet"},{"key":"2026012114053126900_ehf212834-bib-0020","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehi251","article-title":"Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey","volume":"26","author":"Komajda","year":"2005","journal-title":"Eur Heart J"},{"key":"2026012114053126900_ehf212834-bib-0021","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114053126900_ehf212834-bib-0022","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jch.13563","article-title":"Prescription of renin\u2013angiotensin\u2013aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care","volume":"21","author":"Pecoits-Filho","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026012114053126900_ehf212834-bib-0023","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","article-title":"Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with RAAS-inhibitors\u2014Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026012114053126900_ehf212834-bib-0024","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.1199","article-title":"Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists","volume":"20","author":"Trevisan","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114053126900_ehf212834-bib-0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012114053126900_ehf212834-bib-0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCHEARTFAILURE.113.000709","article-title":"Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure","volume":"7","author":"Allen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026012114053126900_ehf212834-bib-0027","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.11904","article-title":"Consistency of laboratory monitoring during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure","volume":"10","author":"Cooper","year":"2015","journal-title":"JAMA"},{"key":"2026012114053126900_ehf212834-bib-0028","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12882-017-0710-7","article-title":"Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care mdash;The NephroTest study","volume":"18","author":"Wagner","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026012114053126900_ehf212834-bib-0029","article-title":"Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey","volume":"28","author":"Rossignol","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026012114053126900_ehf212834-bib-0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","article-title":"Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age","volume":"179","author":"Noel","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2026012114053126900_ehf212834-bib-0031","volume-title":"Atlas de la d\u00e9mographie m\u00e9dicale en France","author":"Bouet","year":"2018"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12834","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12834","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12834","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2042\/65807010\/eschf_7_5_2042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2042\/65807010\/eschf_7_5_2042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:06:02Z","timestamp":1769022362000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/2042\/8372052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,6,29]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12834","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"2020-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}